Susquehanna International Group
LFCR icon

Susquehanna International Group’s Lifecore Biomedical LFCR Stock Holding History

Susquehanna International Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,500
Closed -$135K – 13683
2025
Q4 		$135K Buy
+16,500
New +$122K ﹤0.01% 11254
2025
Q1 		– Sell
-31,500
Closed -$234K – 13034
2024
Q4 		$234K Sell
31,500
-34,300
-52% -$219K ﹤0.01% 10363
2024
Q3 		$324K Buy
65,800
+7,800
+13% +$40.7K ﹤0.01% 9437
2024
Q2 		$298K Sell
58,000
-25,700
-31% -$152K ﹤0.01% 9467
2024
Q1 		$444K Buy
83,700
+17,600
+27% +$126K ﹤0.01% 8796
2023
Q4 		$409K Buy
66,100
+20,400
+45% +$142K ﹤0.01% 9133
2023
Q3 		$345K Sell
45,700
-23,300
-34% -$213K ﹤0.01% 9051
2023
Q2 		$667K Buy
+69,000
New +$421K ﹤0.01% 7631
2018
Q2 		– Sell
-14,000
Closed -$183K – 10028
2018
Q1 		$183K Buy
+14,000
New +$184K ﹤0.01% 8386
2017
Q4 		– Sell
-16,900
Closed -$219K – 9614
2017
Q3 		$219K Sell
16,900
-5,900
-26% -$77.8K ﹤0.01% 7877
2017
Q2 		$339K Buy
+22,800
New +$317K ﹤0.01% 7350
2017
Q1 		– Sell
-16,000
Closed -$221K – 9485
2016
Q4 		$221K Sell
16,000
-6,200
-28% -$85.9K ﹤0.01% 8509
2016
Q3 		$298K Buy
+22,200
New +$269K ﹤0.01% 6941
2015
Q4 		– Sell
-12,600
Closed -$147K – 9711
2015
Q3 		$147K Buy
+12,600
New +$167K ﹤0.01% 8935
2015
Q2 		– Sell
-10,200
Closed -$142K – 10286
2015
Q1 		$142K Buy
+10,200
New +$141K ﹤0.01% 8829

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's LFCR Position: Q1 2026 in Review

Susquehanna International Group reduced its Lifecore Biomedical (LFCR) stake by 59% in Q1 2026, selling an estimated $408K and leaving 40,789 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #11984.

Susquehanna International Group first reported a position in LFCR in Q3 2013 and has held it in 25 quarters since. The position peaked at $3.16M in Q2 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Susquehanna International Group held 40,789 shares of Lifecore Biomedical worth $152K as of Q1 2026.
  • Susquehanna International Group sold 59,092 Lifecore Biomedical shares in Q1 2026, an estimated $408K.
  • Lifecore Biomedical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11984 holding.
  • Susquehanna International Group first reported a position in Lifecore Biomedical in Q3 2013 and has held it in 25 quarters since.
  • Susquehanna International Group's Lifecore Biomedical position peaked at $3.16M in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.